XML 65 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 17 - SEGMENT AND RELATED INFORMATION
12 Months Ended
Jun. 30, 2014
Segment Reporting [Abstract]  
NOTE 17 - SEGMENT AND RELATED INFORMATION

NOTE 17 - SEGMENT AND RELATED INFORMATION

 

The Company provides segment data in accordance with the provisions of ASC topic 280, “Disclosures about Segments of an Enterprise and Related Information”.

 

The Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging centers.

 

The accounting policies of the segments are the same as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company evaluates performance based on income or loss from operations.

 

Summarized financial information concerning the Company’s reportable segments is shown in the following table:

 

   Manufacturing and Servicing of Medical Equipment  Management of Diagnostic Imaging Centers  Totals
Fiscal 2014:         
Net revenues from external customers  $12,070,563   $56,434,914   $68,505,477 
Intersegment net revenues *  $1,963,750   $—     $1,963,750 
Income from operations  $468,793   $11,833,876   $12,302,669 
Depreciation and amortization  $410,728   $3,406,477   $3,817,205 
Compensatory element of stock  issuances  $223,000   $—     $223,000 
Total identifiable assets  $18,093,789   $58,696,054   $76,789,843 
Capital expenditures  $234,275   $600,633   $834,908 

 

Fiscal 2013:

               
Net revenues from external  customers  $14,891,075   $34,250,739   $49,141,814 
Intersegment net revenues *  $1,200,000   $—     $1,200,000 
Income from operations  $139,390   $7,396,357   $7,535,747 
Depreciation and amortization  $541,551   $1,879,626   $2,421,177 
Compensatory element of stock  issuances  $415,021   $—     $415,021 
Total identifiable assets  $15,071,225   $58,079,425   $73,150,650 
Capital expenditures  $237,636   $25,170,303   $25,407,939 

 

.* Amounts eliminated in consolidation

 

Export Product Sales

 

The Company’s areas of operations are principally in the United States. The Company had export sales of medical equipment amounting to 42.4% and 3.8% of product sales revenues to third parties for the years ended June 30, 2014 and 2013, respectively.

 

The foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:

 

   For the Years Ended June 30,
   2014  2013
Abu Dhabi   29.8%   -% 
Switzerland   12.4    —   
England   —      3.6 
Germany   —      0.1 
Libya   0.2    0.1 
    42.4%   3.8%

 

 

Foreign Service and Repair Fees

 

The Company’s areas of service and repair are principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to 8.8% and 8.2% of consolidated net service and repair fees for the years ended June 30, 2014 and 2013, respectively. The foreign service and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries:

 

   For the Years Ended June 30,
   2014  2013
Spain   1.0%   0.9%
Puerto Rico   1.1    1.0 
Switzerland   1.1    1.1 
Germany   .4    —   
England   2.6    2.0 
Holland   1.3    2.2 
Canada   .2    —   
Australia   1.1    1.0 
    8.8%   8.2%

 

The Company does not have any material assets outside of the United States.